Last updated on December 2018

A Study of the Efficacy and Safety of Risankizumab in Subjects With Moderately to Severely Active Crohn's Disease


Brief description of study

The purpose of this study is to evaluate the efficacy and safety of risankizumab versus placebo during induction therapy in subjects with moderately to severely active Crohn's disease (CD).

Clinical Study Identifier: NCT03105128

Contact Investigators or Research Sites near you

Start Over

ABBVIE CALL CENTER

Akershus universitetssykehus /ID# 169378
Nordbyhagen, Norway
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.